Amplia Therapeutics advised that Managing Director Dr. John Lambert, has given notice of his resignation to the Board. It is expected that Dr. Lambert will leave the Company in November 2022 but will be available to assist with an orderly transition of the role.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 AUD | +1.56% | +6.56% | -18.75% |
Apr. 16 | Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing | MT |
Mar. 27 | Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II | MT |
1st Jan change | Capi. | |
---|---|---|
-18.75% | 8.08M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- ATX Stock
- News Amplia Therapeutics Limited
- Amplia Therapeutics Announces Executive Changes